Source :
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866996/Aldo M. Roccaro, Academic Editor There is preclinical evidence that abnormalities in lipid metabolism promote cancer development, and a few studies show the association between lipid levels and multiple myeloma (MM). However, to our knowledge, the role of lipid variability as a risk factor for MM has not been evaluated.